Hypersynchrony in sarcomeric hypertrophic cardiomyopathy: description and mechanistic approach using multimodal

Patricia Réant1,2,3,4,5, Guillaume Bonnet1,2,3,4,5, Frédérique Dubé1,2,6

  • 1Cardiology Department, Bordeaux University Hospital, Bordeaux, France.

Insights

Hypertrophic cardiomyopathy (HCM) alters left ventricular (LV) contraction, with many patients losing the normal apex-to-base delay. This hypersynchrony is linked to distinct electrical activation patterns and smaller LV dimensions, offering insights into HCM mechanics.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Cardiovascular Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by abnormal heart muscle thickening.
  • Little is known about the interplay between mechanical contraction and electrical activation in HCM.
  • Understanding these sequences may help predict response to pacing therapies in obstructive HCM.

Purpose of the Study:

  • To compare left ventricular (LV) mechanical and electrical activation sequences in HCM patients versus healthy controls.
  • To investigate potential differences between obstructive and non-obstructive HCM.
  • To explore associations between contraction patterns and cardiac imaging parameters.

Main Methods:

  • Prospective study of 40 HCM patients (20 obstructive, 20 non-obstructive) and 20 controls.
  • Assessed LV mechanical activation using echocardiography and cardiac MRI.
  • Evaluated electrical activation with 3D electrocardiographic mapping (ECM).

Main Results:

  • Healthy controls exhibited a physiological apex-to-base delay (ABD) in contraction.
  • 18 HCM patients (45%) showed a loss of ABD (hypersynchrony), more than controls (5%).
  • Hypersynchronous HCM patients had smaller LV volumes, lower native T1 values, and a distinct ECM pattern.

Conclusions:

  • LV contraction sequence is altered in HCM, with loss of physiological ABD observed in a significant subset.
  • This altered mechanical sequence correlates with specific electrical activation patterns and smaller LV dimensions.
  • Further research is needed to clarify if these patterns reflect an electrical substrate or cardiac geometry.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...